cep192 (Bethyl)
Structured Review

Cep192, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 60 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cep192/product/Bethyl
Average 93 stars, based on 60 article reviews
Images
1) Product Images from "Bora, CEP192 and Cenexin activate different Plk1 pools and regulate distinct cell and centrosome cycle transitions"
Article Title: Bora, CEP192 and Cenexin activate different Plk1 pools and regulate distinct cell and centrosome cycle transitions
Journal: bioRxiv
doi: 10.1101/2025.09.30.679461
Figure Legend Snippet: (A-H) Representative time stamp images and quantifications from FRAP movies from G2 phase Plk1-EGFP tagged hTERT-RPE1 cells treated with non-targeting siRNA control (A; quantification of recovery in (B)) , Cep192 siRNA (C quantification of recovery in (D)) , Cenexin siRNA (E quantification of recovery in (F)) and siCep192 + siCenexin (G quantification of recovery in (H)) . (I) Box and Whisker plot for measurement of mobile Plk1 pool on centrosomes under indicated conditions (N=3 independent experiments; n= 43, 44, 43 and 45 for siControl, siCep192, siCenexin and siCep192 + siCenexin, respectively.) (J) Box and Whisker plot for measurement of mobile Plk1 pool on centrosomes after Plk1 inhibition derived from N=3 independent experiments comprising n= 43, and 53 individual cells for DMSO and Plk1i, respectively. (K) Representative immunofluorescence images of hTERT-RPE1: Plk1-EGFP cells treated with indicated siRNAs and stained for Pericentrin (Red) and EGFP (Green). (L) Box and Whisker plot for measurement of Plk1 levels on centrosomes during G2 phase under the conditions indicated in (K) generated from N=5 independent experiments comprising n= 287: siControl, 279: siBora, 276: siCep192 and 287: siCenexin cells. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars Images: 5 µm and zoomed insets: 0.5 µm.
Techniques Used: Control, Whisker Assay, Inhibition, Derivative Assay, Immunofluorescence, Staining, Generated
Figure Legend Snippet: (A) Live-cell time-lapse images of hTERT-RPE1: mRuby-PCNA cells treated with indicated siRNA combinations as they progress through S phase. (B) Box and whisker plot for measurement of the duration of S phase in cells after depletion of proteins indicated in (A) . Data derived from N=3 independent experiments comprising n= 45: siBora + Cep192, 52: siCep192 + siCenexin, 57: siBora + siCenexin and 51: siBora + siCep192 + siCenexin cells. (C) Live-cell time-lapse images of hTERT-RPE1: mRuby-PCNA cells treated with indicated siRNA combinations as they progress through G2 phase. (D) Box and whisker plot for measurement of the duration of S phase in cells after depletion of proteins indicated in (A) . Data derived from N=3 independent experiments comprising n= 82: siBora + Cep192, 56: siCep192 + siCenexin, 64: siBora + siCenexin and 71: siBora + siCep192 + siCenexin cells. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars: 5 µm.
Techniques Used: Whisker Assay, Derivative Assay
Figure Legend Snippet: (A-C) Flow cytometry-based quantification of cell cycle profile of hTERT-RPE1 (WT), hTERT-RPE1: Usp28 - / - and hTERT-RPE1: Usp28 - / - 0:0 cells revealing percentage of cells in G1 (A) , S (B) and G2 (C) phases derived from N=4 independent experiments with each treatment comprising around 30,000 cells. (D) Flow cytometry-based quantification of cell cycle profile or RPE1 cells treated with Control vs Cep192 siRNA showing percentage of cells in G1, S and G2 phases obtained from N=5 independent experiments with each treatment comprising of 30,000 cells. (E) Representative images of S phase hTERT-RPE1 cells expressing cellular Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (F) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from S phase cells represented in (E) derived from N=4 independent experiments comprising n= 203: siControl, 204: siBora, 215: siCep192, 219: siCenexin, 215: Plk1i cells. The leftmost G2 Phase – siControl bar shown is replica of siControl data shown in for side-by-side comparison purposes. G) Representative images of S phase hTERT-RPE1 cells expressing centrosomal Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (H) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from S phase cells represented in (G) derived from N=3 independent experiments comprising n= 163: siControl, 187: siBora, 187: siCep192, 184: siCenexin, 178: Plk1i cells. The leftmost G2 Phase – siControl bar shown is replica of siControl data shown in for side-by-side comparison purposes. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars, Images: 5 µm and zoomed insets: 0.5 µm.
Techniques Used: Flow Cytometry, Derivative Assay, Control, Expressing, Activity Assay, Whisker Assay, Comparison
